Already a DIA Member? Sign in. Not a member? Join.

Iniciar sesión

¿Ha olvidado su ID de usuario? or ¿Ha olvidado su contraseña?

Not a Member?

Create Account and Join

Nihonbashi Life Science HUB

25 oct 2018 9:00 a.m. - 26 oct 2018 6:00 p.m.

8F, 1-5-5 Nihonbashi-muromachi, Chuo-ku, Tokyo, 103-0022 Japan

7th DIA Cardiac Safety Workshop in Japan

It will be a unique opportunity to learn of and discuss the current state and future directions of CV risk assessments and how to prepare for a new regulatory paradigm.

[Session 5] Strategies for Early Detection of Cardiotoxicity

Session Chair(s)

Atsushi  Sugiyama, MD, PhD

Atsushi Sugiyama, MD, PhD

Professor and Chairman, Department of Pharmacology

Toho University Faculty of Medicine, Japan

Kyosuke  Takeshita, MD, PhD

Kyosuke Takeshita, MD, PhD

Department of Clinical Laboratory Medicine

Saitama Medical Center, Saitama Medical University, Japan

Speaker(s)

Hiroshi  Akazawa, MD, PhD

Integrated Approach to Early Detection of Drug-Induced Cardiotoxicity

Hiroshi Akazawa, MD, PhD

The University of Tokyo, Japan

Lecturer, Graduate School of Medicine and Faculty of Medicine

Kyosuke  Takeshita, MD, PhD

Imaging Biomarkers for Early Detection of Drug-Induced Cardiotoxicity

Kyosuke Takeshita, MD, PhD

Saitama Medical Center, Saitama Medical University, Japan

Department of Clinical Laboratory Medicine

Najah  Abi-Gerges, PhD

Preclinical Human Contractility Safety Testing

Najah Abi-Gerges, PhD

AnaBios Corporation, United States

Vice President, Research & Development

¿Tiene una cuenta?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.